Physician

Ningxi Zhu, M.D.

According to 2025 Medicare claims, Ningxi Zhu, M.D. (NPI: 1487948121) practices pediatric medicine in the Corpus Christi, TX market, with the plurality of this provider's patient population coming from Nueces, TX. This provider's primary affiliated billing organization is ALLERGY AND IMMUNOLOGY SPECIALISTS OF CORPUS CHRISTI, PA (NPI: 1013947720; TIN: 742760860) and primary practice location at 78412-4584.

Zhu's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 192 traditional Medicare patients, billed 12,430 HCPCS/CPT codes, and received $344,219 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 2,166 prescription claims across 304 beneficiaries totaling $544,101 in drug costs, led by Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter). 2022 DME data shows 12 claims. Open Payments data shows 106 records totaling $2,509. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $21,201 to $344,219. Similarly, Part D prescription costs have risen steadily, from $35,269 to $544,101. In contrast, DME billing represents a smaller volume and did not follow a clear longitudinal pattern.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	92	1,837	$21,201
2016	83	1,340	$15,706
2017	108	2,171	$23,640
2018	218	3,395	$38,018
2019	233	4,257	$47,651
2020	207	2,984	$35,469
2021	211	3,630	$51,567
2022	196	8,343	$170,877
2023	187	12,391	$315,626
2024	192	12,430	$344,219

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	70	323	$35,269
2016	76	430	$55,465
2017	102	481	$85,837
2018	225	1,065	$263,588
2019	299	2,099	$576,883
2020	278	2,123	$670,516
2021	278	2,025	$657,151
2022	263	1,815	$576,248
2023	250	1,940	$639,588
2024	304	2,166	$544,101

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	36	$461
2020	N/R	12	$316
2021	N/R	11	$40
2022	N/R	12	$98
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	27	27	$109
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	118	160	$84
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	42	43	$62
94010	Test to measure expiratory airflow and volume	94	123	$19
95004	Test for allergy using allergenic extract	27	1,803	$3

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	187	7,530	$153,178
Xolair	Omalizumab	24	672	$66,653
Dupixent Syringe	Dupilumab	16	448	$59,589
Breo Ellipta	Fluticasone/Vilanterol	83	3,390	$43,549
Spiriva Respimat	Tiotropium Bromide	38	1,620	$27,846

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	106	$2,509	GlaxoSmithKline, LLC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ningxi Zhu, M.D.?

Tedicare shows public-source Medicare data for Ningxi Zhu, M.D. (NPI 1487948121), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ningxi Zhu, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Ningxi Zhu, M.D.?

Ningxi Zhu, M.D. is linked to ALLERGY AND IMMUNOLOGY SPECIALISTS OF CORPUS CHRISTI, PA (billing NPI 1013947720) in the available physician profile data.

Does Ningxi Zhu, M.D. have Open Payments data?

Ningxi Zhu, M.D. has 106 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.